BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32803849)

  • 1. Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design.
    Salmaso V; Jacobson KA
    ChemMedChem; 2020 Nov; 15(21):1958-1973. PubMed ID: 32803849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I
    Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pharmacology of P2Y receptor subtypes.
    von Kügelgen I
    Biochem Pharmacol; 2021 May; 187():114361. PubMed ID: 33309519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update of P2Y receptor pharmacology: IUPHAR Review 27.
    Jacobson KA; Delicado EG; Gachet C; Kennedy C; von Kügelgen I; Li B; Miras-Portugal MT; Novak I; Schöneberg T; Perez-Sen R; Thor D; Wu B; Yang Z; Müller CE
    Br J Pharmacol; 2020 Jun; 177(11):2413-2433. PubMed ID: 32037507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of P2Y receptors.
    von Kügelgen I
    Brain Res Bull; 2019 Sep; 151():12-24. PubMed ID: 30922852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pharmacology of P2Y-receptors.
    von Kügelgen I; Wetter A
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):310-23. PubMed ID: 11111826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and structure of P2Y receptors.
    von Kügelgen I; Hoffmann K
    Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2Y1 and P2Y13 purinergic receptors mediate Ca2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells.
    Lyubchenko T; Woodward H; Veo KD; Burns N; Nijmeh H; Liubchenko GA; Stenmark KR; Gerasimovskaya EV
    Am J Physiol Cell Physiol; 2011 Feb; 300(2):C266-75. PubMed ID: 20962269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of P2Y receptor subtypes - an update.
    von Kügelgen I
    Purinergic Signal; 2024 Apr; 20(2):99-108. PubMed ID: 37697211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tools and drugs for uracil nucleotide-activated P2Y receptors.
    Rafehi M; Müller CE
    Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current knowledge on the nucleotide agonists for the P2Y2 receptor.
    Xu P; Feng X; Luan H; Wang J; Ge R; Li Z; Bian J
    Bioorg Med Chem; 2018 Jan; 26(2):366-375. PubMed ID: 29254895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of P2Y receptors to Ca
    Kotova PD; Bystrova MF; Rogachevskaja OA; Khokhlov AA; Sysoeva VY; Tkachuk VA; Kolesnikov SS
    Cell Calcium; 2018 May; 71():1-14. PubMed ID: 29604959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior.
    Malin SA; Molliver DC
    Mol Pain; 2010 Apr; 6():21. PubMed ID: 20398327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.
    Ciancetta A; Jacobson KA
    Methods Mol Biol; 2018; 1705():45-72. PubMed ID: 29188558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.
    Jacobson KA; Paoletta S; Katritch V; Wu B; Gao ZG; Zhao Q; Stevens RC; Kiselev E
    Mol Pharmacol; 2015 Aug; 88(2):220-30. PubMed ID: 25837834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic neuropathic pain: purine receptor modulation.
    Jacobson KA; Giancotti LA; Lauro F; Mufti F; Salvemini D
    Pain; 2020 Jul; 161(7):1425-1441. PubMed ID: 32187120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2 receptors activated by uracil nucleotides--an update.
    Brunschweiger A; Müller CE
    Curr Med Chem; 2006; 13(3):289-312. PubMed ID: 16475938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.